Showing results (11-20 of 256) with videos related to
Sort By:
Pageof 26
Cancer Immunology, Immunotherapy : CII|April 26, 2006
Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surfaceJeannette Gerspach, Julia Németh, Sabine Münkel, et al.Glia|December 7, 2013
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factorRoman Fischer, Harald Wajant, Roland Kontermann, et al.The FEBS Journal|April 10, 2008
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilizationNicole Müller, Agnes Wyzgol, Sabine Münkel, et al.Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosisDaniela Siegmund, Philipp Hadwiger, Klaus Pfizenmaier, et al.The Journal of Biological Chemistry|July 10, 2002
Endogenous membrane tumor necrosis factor (TNF) is a potent amplifier of TNF receptor 1-mediated apoptosisMonika Weingärtner, Daniela Siegmund, Ulrich Schlecht, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2009
Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligandAgnes Wyzgol, Nicole Müller, Andrea Fick, et al.Cellular Signalling|September 3, 2010
Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathwayRoman Fischer, Olaf Maier, Matthias Naumer, et al.European Journal of Biochemistry|October 2, 2002
Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4)Heike Glauner, Daniela Siegmund, Hassan Motejadded, et al.Journal of Molecular Medicine (Berlin, Germany)|August 23, 2006
A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95Constance Assohou-Luty, Jeanette Gerspach, Daniela Siegmund, et al.The Journal of Biological Chemistry|May 30, 2003
Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted ActivationDierk Samel, Dafne Muller, Jeannette Gerspach, et al.Pageof 26